Trial Profile
Ambien CR [zolpidem extended-release] vs. placebo for treatment of insomnia associated with anxiety when used concomitantly with escitalopram (Lexapro).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Zolpidem (Primary) ; Escitalopram
- Indications Generalised anxiety disorder; Insomnia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanofi
- 01 Jun 2009 Results published in the Journal of Clinical Psychopharmacology.
- 03 May 2008 Results have been presented at the 161st Annual Meeting of the American Psychiatric Association.
- 02 Nov 2006 Status change